FAQs About GLP-1 and Weight Loss Some patients see changes within the first month, but significant results typically become visible between 23 months
Obesity Three of the GLP-1 RAs are FDA approved for obesity: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) (these have separate brands for diabetes and obesity, and we have listed the diabetes brand first)
10.4 How are peptides administered
Per the brand, the formula centers on Akkermansia muciniphila (a gut bacterium) and artichoke-derived inulin (a prebiotic fiber), with a supporting Vitamin B Complex covering B1, B2, B3, B5, B6, and B12
Many Canadians report spending thousands of dollars on various interventions before finding lasting relief
Administration routes vary: subcutaneous injections for systemic peptides, oral forms when bioavailability allows, and topical or intra-vaginal formulations when local delivery reduces systemic exposure